The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...

Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...